Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2019-11-21

Clinical Trial Update: A Single-arm Phase II Study of Post-Transoral Robotic Surgery (TORS) Alone to the Primary Tumor Site and Selective Neck Dissection (SND) Followed by Adjuvant Radiation Therapy (+/- Chemotherapy) to the Regional Nodes for Advanced Stage, Human Papilloma Virus (HPV) Positive, Oropharyngeal Cancer [Phase 2]

View source ↗

Summary

Phase II single-arm trial evaluating post-TORS with selective neck dissection followed by adjuvant radiotherapy (± chemotherapy) for HPV-positive oropharyngeal …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Abramson Cancer Center at Penn Medicine | Conditions: Oropharyngeal Cancer | Phase 2 | Status: COMPLETED | Results posted: 2019-11-21